Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Koller

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Cancers|March 11, 2023
Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract CancerDino Bekric, Daniel Neureiter, Celina Ablinger, et al.
Human Molecular Genetics|September 24, 2010
K14 mRNA reprogramming for dominant epidermolysis bullosa simplexVerena Wally, Marietta Brunner, Thomas Lettner, et al.
International Journal of Molecular Sciences|January 9, 2015
Trans-splicing improvement by the combined application of antisense strategiesUlrich Koller, Stefan Hainzl, Thomas Kocher, et al.
Nucleic Acids Research|June 21, 2011
A novel screening system improves genetic correction by internal exon replacementUlrich Koller, Verena Wally, Lloyd G Mitchell, et al.
International Journal of Molecular Sciences|March 10, 2018
RNA Trans-Splicing Modulation via Antisense Molecule InterferenceBernadette Liemberger, Josefina Piñón Hofbauer, Verena Wally, et al.
Molecular Therapy. Nucleic Acids|March 2, 2016
A Gene Gun-mediated Nonviral RNA trans-splicing Strategy for Col7a1 RepairPatricia Peking, Ulrich Koller, Stefan Hainzl, et al.
Experimental Dermatology|July 5, 2016
RNA-based therapies for genodermatosesOlivier Bornert, Patricia Peking, Jeroen Bremer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 9, 2024
On- and off-target effects of paired CRISPR-Cas nickase in primary human cellsJulia Klermund, Manuel Rhiel, Thomas Kocher, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 13, 2017
COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis BullosaStefan Hainzl, Patricia Peking, Thomas Kocher, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 11, 2017
Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 NickasesThomas Kocher, Patricia Peking, Alfred Klausegger, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Cancers|March 11, 2023
Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract CancerDino Bekric, Daniel Neureiter, Celina Ablinger, et al.
Human Molecular Genetics|September 24, 2010
K14 mRNA reprogramming for dominant epidermolysis bullosa simplexVerena Wally, Marietta Brunner, Thomas Lettner, et al.
International Journal of Molecular Sciences|January 9, 2015
Trans-splicing improvement by the combined application of antisense strategiesUlrich Koller, Stefan Hainzl, Thomas Kocher, et al.
Nucleic Acids Research|June 21, 2011
A novel screening system improves genetic correction by internal exon replacementUlrich Koller, Verena Wally, Lloyd G Mitchell, et al.
International Journal of Molecular Sciences|March 10, 2018
RNA Trans-Splicing Modulation via Antisense Molecule InterferenceBernadette Liemberger, Josefina Piñón Hofbauer, Verena Wally, et al.
Molecular Therapy. Nucleic Acids|March 2, 2016
A Gene Gun-mediated Nonviral RNA trans-splicing Strategy for Col7a1 RepairPatricia Peking, Ulrich Koller, Stefan Hainzl, et al.
Experimental Dermatology|July 5, 2016
RNA-based therapies for genodermatosesOlivier Bornert, Patricia Peking, Jeroen Bremer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 9, 2024
On- and off-target effects of paired CRISPR-Cas nickase in primary human cellsJulia Klermund, Manuel Rhiel, Thomas Kocher, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 13, 2017
COL7A1 Editing via CRISPR/Cas9 in Recessive Dystrophic Epidermolysis BullosaStefan Hainzl, Patricia Peking, Thomas Kocher, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 11, 2017
Cut and Paste: Efficient Homology-Directed Repair of a Dominant Negative KRT14 Mutation via CRISPR/Cas9 NickasesThomas Kocher, Patricia Peking, Alfred Klausegger, et al.
Pageof 8